Thymosin Beta 4 Ophthalmic Solution for Dry Eye: A Randomized, Placebo-Controlled, Phase II Clinical Trial Conducted Using the Controlled Adverse Environment (CAE™) Model
Clinical Ophthalmology - New Zealand
doi 10.2147/opth.s80954
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2015
Authors
Publisher
Informa UK Limited